LORRI HINTON: Open Payments
NPI 1366054389 · CLARION, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 48 payments from 20 companies in 2025. Trend: 2023 $54 · 2024 $641 · 2025 $1,123
Food & beverage: $945Education: $178
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 13 | $275 |
| Janssen Biotech, Inc. | 5 | $176 |
| Novartis Pharmaceuticals Corporation | 4 | $117 |
| Merck Sharp & Dohme LLC | 4 | $90 |
| Eisai Inc. | 2 | $50 |
| Rigel Pharmaceuticals, Inc. | 2 | $49 |
| Acrotech Biopharma Inc. | 2 | $43 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $42 |
| Stemline Therapeutics Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
Products named: Enhertu, RYBREVANT, SCEMBLIX, KEYTRUDA, ERLEADA, Lenvima, KISQALI, TAVALISSE.
Industry payments across PA — which companies pay providers there.
